miR-181d-5p Protects against Retinal Ganglion Cell Death after Blunt Ocular Injury by Regulating NFIA-Medicated Astrocyte Development

Mediators Inflamm. 2022 Oct 8:2022:5400592. doi: 10.1155/2022/5400592. eCollection 2022.

Abstract

Background: Traumatic optic neuropathy (TON) refers to damage to the optic nerve resulting from direct and indirect trauma to the head and face. One of the important pathological processes in TON is the death of retinal ganglion cells (RGCs), but the cause of RGCs death remains unclear. We aimed to explore the mechanisms of RGCs death in an experimental TON model.

Methods: Optic nerve crush injury was induced in ten New Zealand white rabbits. On the 1st, 3rd, 7th, 14th, and 28th days after the operation, the retinal tissues of the rabbits were observed pathologically by hematoxylin-eosin staining. The expression of POU-homeodomain transcription factor Brn3a and glial fibrillary acidic protein (GFAP) was measured by immunofluorescence to evaluate the number of RGCs and astrocytes, respectively. miRNA expression and protein levels were assessed by RT-qPCR and western blot methods, respectively. Finally, the malondialdehyde content, superoxide dismutase activity, and proinflammatory factor levels were measured by ELISA. Western blot and dual-luciferase reporter assays were used to elucidate the relationship between miR-181d-5p and nuclear factor I-A (NFIA).

Results: Blunt ocular trauma increased oxidative stress and apoptosis and reduced ganglion cell layer (GCL) density. The expression of miR-181d-5p was decreased in retinal tissues, and its overexpression relieved RGCs death, astrocyte development, oxidative stress, and inflammation of the retina, which were reversed by NFIA overexpression.

Conclusion: miR-181d-5p can protect against the deterioration of TON by inhibiting RGCs death, astrocyte development, oxidative stress, and inflammation by targeting NFIA. This study provides new insight into early medical intervention in patients with TON.

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Eosine Yellowish-(YS) / metabolism
  • Eosine Yellowish-(YS) / therapeutic use
  • Glial Fibrillary Acidic Protein / metabolism
  • Hematoxylin / metabolism
  • Hematoxylin / therapeutic use
  • Inflammation / metabolism
  • Malondialdehyde / metabolism
  • MicroRNAs* / metabolism
  • NFI Transcription Factors / metabolism
  • Optic Nerve Injuries*
  • Rabbits
  • Retinal Ganglion Cells / metabolism
  • Retinal Ganglion Cells / pathology
  • Superoxide Dismutase / metabolism

Substances

  • Eosine Yellowish-(YS)
  • Glial Fibrillary Acidic Protein
  • Hematoxylin
  • Malondialdehyde
  • MicroRNAs
  • NFI Transcription Factors
  • Superoxide Dismutase